ClinicalTrials.Veeva

Menu

Important Data on COVID-19 Profile in Africa (AIDCO)

C

Centre de Recherche Médicale de Lambaréné

Status

Completed

Conditions

Africa
Coronavirus Infection

Study type

Observational

Funder types

Other

Identifiers

NCT04847817
CEI-10/2020 (Other Identifier)
0011/2020/PR/SG/CNE

Details and patient eligibility

About

The purpose of this study is to Understand the natural history of Coronavirus 2019 (COVID-19) infection to better define the period of infectiousness and transmissibility and to establish biobanks of COVID-19 blood and mucosal samples.

Full description

In this study ,the participants will be enrolled sequentially in the COVID-19 care referral centers. The infected hospitalized patient will be identified by the physicians in hospital. After the patient has given his/her informed consent the permission will be sought from him to approach his household contacts. The household contacts will be screened, and included in the study.

Patients hospitalized and positive for COVID-19 by PCR and their household contacts of all ages and gender (40% minimum of female), will be enrolled upon receipt of written informed consent.

Enrollment

574 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Molecular (PCR) confirmed COVID-19 patients hospitalized in referral centers,
  • Household contacts of hospitalized COVID-19 patient,
  • Provided signed informed consent.

Exclusion criteria

  • Pregnancy

Trial design

574 participants in 2 patient groups

Index cases
Description:
Patients infected by SARS-Cov2 Polymerase Chain Reaction (PCR) and hospitalized in a referral center for COVID-19 .
Households cases
Description:
Household contacts of SARS-Cov2 hospitalized COVID-19 patients.

Trial contacts and locations

2

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems